CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 TGD.US 1 out of 5 Outperform 5Y $1.70 $1.04 (-2.80%) -39.42% +10.52% -49.94
17/03/2014 FNV.US 3 out of 5 Outperform 5Y $51.81 $54.56 (-0.09%) +5.41% +10.52% -5.11
17/03/2014 GDXJ.US 4 out of 5 Outperform 5Y $44.00 $27.40 (-0.80%) -37.84% +10.52% -48.36
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $1.05 (-4.55%) -45.36% +10.52% -55.88
17/03/2014 AEM.US 3 out of 5 Outperform 5Y $34.00 $32.02 (-1.66%) -5.68% +10.52% -16.20
17/03/2014 ANV.US 2 out of 5 Outperform 5Y $6.37 $1.07 (-6.95%) -83.20% +10.52% -93.72
17/03/2014 GG.US 3 out of 5 Outperform 5Y $27.92 $23.44 (-2.08%) -16.00% +10.52% -26.52
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $308.82 (-1.14%) +72.18% +49.34% -22.83
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $2.70 (-4.08%) -56.52% +37.00% -93.52
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $4.62 (+1.54%) +2.91% +35.17% -32.26
11/02/2013 PAAS.US 4 out of 5 Outperform 5Y $16.13 $11.27 (+0.81%) -29.97% +35.17% -65.14
05/02/2013 RIC.US 2 out of 5 Outperform 5Y $3.20 $3.48 (-0.14%) +8.44% +36.42% -27.98
05/02/2013 AXU.US 4 out of 5 Outperform 5Y $4.58 $0.59 (-5.12%) -87.40% +36.42% -123.82
04/02/2013 SSRI.US 4 out of 5 Outperform 5Y $12.09 $6.44 (+0.15%) -46.82% +36.45% -83.26
04/02/2013 GORO.US 2 out of 5 Outperform 5Y $12.50 $3.44 (-1.43%) -72.19% +36.45% -108.64
24/01/2013 SGSVF.US 2 out of 5 Outperform 5Y $2.51 $0.32 (+1.71%) -87.44% +37.52% -124.96
23/01/2013 NRT.US 5 out of 5 Outperform 1Y $21.28 $12.96 (+0.08%) -39.14% +37.54% -76.68
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $5.85 (+3.54%) +12.26% +37.54% -25.28
23/01/2013 POT.US 5 out of 5 Outperform 5Y $38.52 $35.76 (-0.35%) -6.70% +37.54% -44.24
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $2.70 (-4.26%) -74.29% +39.64% -113.93
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.